Page URL: https://www.bionews.org.uk/page_135827

Gene protecting against leukaemia found in males

14 May 2018
Appeared in BioNews 949

Scientists have discovered the first male-only gene that appears to protect against cancers including leukaemia.

In a study published in Nature Genetics, researchers set out to study a gene called UTX which is found on the X chromosome that is known to be mutated in several cancers including acute myeloid leukaemia (AML). However, they discovered that a related gene found on the Y chromosome, UTY, protected male mice from AML.

They also found that in AML and several other human cancers, mutations in UTX were accompanied by a loss of UTY, suggesting that this cancer-suppressing role of UTY extends beyond AML.

AML is an aggressive blood cancer that affects people of all ages, but is most common in older people. It develops in cells in the bone marrow and leads to life-threatening infections and bleeding. Mainstream AML treatments have remained unchanged for decades and fewer than 20 percent of those affected survive for five years after diagnosis.

'This is the first Y chromosome-specific gene that protects against AML,’ said Dr Malgorzata Gozdecka at the Wellcome Sanger Institute in Hinxton, and first author of the study. 'Previously it had been suggested that the only function of the Y chromosome is in creating male sexual characteristics, but our results indicate that the Y chromosome could also protect against AML and other cancers.'

Women have two X chromosomes while men have one X and one Y chromosome. The X and Y chromosomes share many genes, but a small number of genes, including UTY, are only found on the Y chromosome. The discovery of this new role changes the way the Y chromosome is viewed and improves understanding of how AML and other cancers develop.

'Survival rates for AML remain tragically low, with current treatment that involves intensive chemotherapy, often combined with a stem cell transplant, only curing a small proportion of patients,' said Dr Alasdair Rankin, Director of Research at the charity Bloodwise in London, which part-funded the research.

'This important research helps build a fuller picture of what goes wrong genetically as this highly aggressive leukaemia develops. Understanding this process is key to developing targeted drugs for AML, allowing us to move away from gruelling and often ineffective chemotherapy-based treatments.'

RELATED ARTICLES FROM THE BIONEWS ARCHIVE
27 November 2017 - by Dr Sam Sherratt 
A new gene therapy for leukaemia is effective for a majority of patients who showed resistance to previous therapies...
21 August 2017 - by Emma Laycock 
High doses of vitamin C may help fight certain leukaemias by boosting the activity of a particular gene, suggests a new study...
25 January 2017 - by Dr Loredana Guglielmi 
Doctors at London's Great Ormond Street Hospital have used genome editing to successfully treat two children with leukaemia...
15 April 2013 - by Dr Katie Howe 
Genome analysis of identical twins with childhood leukaemia has helped pinpoint genetic mutations which may kick-start the disease in the mother's womb...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.